Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOXD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF776 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FOSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
VWA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QKI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HFE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GID8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on